Page 387 - 2021 IDMT Digital

ANAPHYLAXIS CONTINUED
Assessment:
• 'LIIHUHQWLDO
o $OOHUJLF UKLQLWLV OHVV VHYHUH (17 DQG UHVSLUDWRU\ V\PSWRPV
o )RRG DOOHUJ\ XVXDOO\ SUHVHQWV ZLWK VNLQ V\PSWRPV DQG UHVSLUDWRU\ V\PSWRPV DUH
OHVV VHYHUH
o /DWH[ VHQVLWLYLW\ OHVV VHYHUH UHDFWLRQ OLNHO\ WR EH OLPLWHG WR GHUPDWLWLV
o 0DVWRF\WRVLV PDVW FHOO LQILOWUDWLRQ RI VNLQ DQG RWKHU RUJDQV V\PSWRPV LQFOXGH
SUXULWXV DQG G\VSHSVLD
o &RQVLGHU DOO RWKHU FDXVHV RI VKRFN DQG K\SRWHQVLRQ L H , VHSVLV
Plan:
• (9$& RU WUDQVIHU
• 3UHSDUH IRU $&/6 LQWHUYHQWLRQ
o 2[\JHQ
o 3RVVLEOH LQWXEDWLRQ
o ,VRWRQLF ,9 IOXLGV
• 0HGLFDWLRQV
o (SLQHSKULQH ,0 (preferred) ,9 FRUQHUVWRQH RI WUHDWPHQW
ƒ ,0 , VROXWLRQ
ƒ ,9 VROXWLRQ
o $QWLKLVWDPLQHV ,9
ƒ + EORFNHUV GLSKHQK\GUDPLQH SOXV + EORFNHUV ranitidine
o ,QKDOHG EHWD DJRQLVWV DOEXWHURO
o &RUWLFRVWHURLGV ,9
Patient Education:
• 3ULPDU\ SUHYHQWLRQ LV DYRLGDQFH RI NQRZQ WULJJHUV
• 'HVHQVLWL]DWLRQ LV XVHG IRU DOOHUJHQ WULJJHUV WKDW FDQQRW UHOLDEO\ EH DYRLGHG L H , LQVHFW
VWLQJV
• 3DWLHQWV ZLWK NQRZQ DQDSK\ODFWLF UHDFWLRQV VKRXOG ZHDU DQ DOHUW EUDFHOHW DQG FDUU\ D
SUH ILOOHG HSLQHSKULQH V\ULQJH
• )ROORZ 8S $FWLRQV
o (QFRXUDJH FRPSOLDQFH ZLWK DOO PHGLFDO FDUH
o )ROORZ XS IRU DQ\ QHZ SRVVLEOH DOOHUJLF UHDFWLRQV RU WULJJHUV
o 3UH ILOOHG HSLQHSKULQH V\ULQJHV VKRXOG EH SUHVFULEHG \HDUO\
Preceptor Directive:
• Red Directive: Immediate Evacuation; Contact Preceptor ASAP

[ 386 ]